封面
市場調查報告書
商品編碼
1627766

認知功能補充品市場:預測(2025-2030)

Cognition Supplements Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球認知功能補充劑市場預計複合年成長率為 13.79%,從 2025 年的 148.1 億美元成長到 2030 年的 274.3 億美元。

這些精神藥物(認知補充劑)聲稱可以改善記憶力、注意力和整體大腦功能。咖啡因、銀杏葉、假馬齒莧和Omega-3脂肪酸是常見成分。

想要保持思維敏捷的老齡化人群對認知健康解決方案的需求正在推動認知補充劑市場的發展。壓力水平上升、忙碌的生活方式以及阿茲海默症認知疾病的發生進一步推動了市場成長。證明特定物質有效性的研究和技術發展也有助於市場擴張。此外,隨著人們越來越重視一般大腦健康和認知表現,預防保健和自我護理的趨勢正在推動對認知補充劑的需求。

據世界衛生組織(WHO)稱,世界人口正在迅速老化。到2020年,全球將有10億人年齡超過60歲。到 2030 年,這個數字將增加到 14 億,也就是地球上六分之一的人口。此外,到 2050 年,60 歲及以上的人口數量將加倍,達到 21 億。 2020年至2050年間,80歲及以上的人口數量預計將增加兩倍,達到4.26億。

此外,為了應對不斷變化的消費者偏好,認知補充劑行業的市場公司正在投資創新配方的研究,建立策略夥伴關係關係以擴大分銷範圍,並使用品牌和行銷技術等各種策略來吸引客戶。

此外,基於臨床和科學證據,Provi(R) Sensia 是一種新穎的益生菌理念,可以改善情緒和睡眠質量,改善工作記憶和學習,並促進認知能力的增強。這些大腦過程對於改善人們的整體心理健康至關重要。這種新的益生菌解決方案是在當地支持下量身定做的,可滿足不同的消費者需求,並得到全球健康聲明的支持。

總體而言,由於人口老化、認知健康意識增強以及對增強性能產品的需求增加等原因,認知功能補充劑市場正在顯著擴大。市場參與企業採用各種策略,包括品牌宣傳活動、策略聯盟和研發,以在這個不斷變化的環境中保持競爭力。此外,由於消費者偏好的變化以及技術進步開發更有效配方的能力,認知功能補充劑市場預計未來將會成長。

全球認知功能補充品市場的促進因素

  • 精神疾病增加

認知功能補充劑市場預計將受到精神疾病預期增加的顯著推動。包括焦慮症、憂鬱症和過動症在內的全球疾病盛行率不斷上升,對增強心理健康的補充和替代方法提出了更大的需求。聲稱可以提升情緒、減輕壓力和增強認知功能的補充劑稱為認知補充劑,旨在滿足這種需求。隨著人們尋找預防和治療心理健康問題的方法,認知功能補充品市場預計將在未來幾年大幅擴張。這顯示了該行業的創新和成長潛力。

據估計,到 2021 年,美國將有 5,780 萬名 18 歲及以上的人患有 AMI。這個數字佔所有美國成年人的 22.8%。女性 AMI 發生率 (27.2%) 高於男性 (18.1%)。 AMI 發生率在年輕人(18-25 歲)中最高(33.7%),其次是成年人(26-49 歲;28.1%)和老年人(15.0%)。

在具有兩種或多種種族認同的成年人中,AMI 最常見 (34.9%),其次是美洲印第安人或阿拉斯加原住民 (AI/AN) 的人 (26.6%)。亞洲成年人的 AMI 發生率最低(16.4%)。

此外,在印度,政府實施了國家心理健康計劃(NMHP),以提供方便且價格合理的心理保健設施。國家衛生使命向各州和首府支持地區心理健康計劃 (DMHP),該計劃是 NMHP 的組成部分,該計劃已獲核准在 704 個地區實施。 DMHP 為殘障人士提供門診病人服務、評估、諮詢、社會心理干預、持續護理和支持、藥物治療以及社區健康中心 (CHC) 和初級衛生中心 (PHC) 層面的推廣服務、救護車服務和其他服務。

此外,自我報告的精神和行為障礙是澳洲統計局 (ABS) 2020-2021 年國家健康調查 (NHS) 涵蓋的眾多健康問題之一。只有當該人聲明該疾病已持續或預計將持續六個月或更長時間時,NHS 才會在收集期間將其記錄為患有精神或行為障礙。根據 NHS 2020-2021 (ABS 2022b),五分之一 (20%) 15 歲及以上的澳洲人在收集期間(2020 年 8 月至 2021 年 6 月)存在精神或行為問題,推測患有殘疾。

全球認知補充品市場的地理前景

  • 在全球認知功能補充品市場中,美國在北美地區預計將佔據較大佔有率。

老化是失智症和認知障礙的主要原因之一。美國老年人的數量正在穩定增加,導致失智症心理健康問題的盛行率增加。在預測期內,這預計將擴大產品應用範圍並推動整體市場成長。例如,老年失智症失智症的盛行率隨著年齡的成長而增加,在美國, 65歲至74歲的人中有5.0%,75歲至84歲的人有13.1%,85歲及以上的人有33.3%。

此外,近年來,消費者的偏好已轉向含有抹茶、咖啡因、甜菜根、菠菜、婆羅米、北極根、薑黃、人參和松樹皮等成分的草藥保健產品。此外,美國素食者數量的不斷增加預計將增加對草藥產品的需求。

此外,該地區的營養保健品和天然補充劑行業已經很成熟,很可能在預測期內促進高速成長。例如,2020 年美國膳食補充劑的總銷售額預計為 557 億美元,其中含有維生素、礦物質或兩者兼有的補充劑的銷售額為 212 億美元,複合綜合維他命/礦物質(MVM) 的銷售額為80 億綜合維他命。

此外,焦慮、壓力和憂鬱症等心理健康問題的普遍存在也支持了該行業的成長。例如,美國焦慮和憂鬱症協會估計有 680 萬美國成年人患有整體焦慮症 (GAD)。

此外,社群媒體平台對消費者決策的影響力也越來越大。此外,隨著越來越多的人意識到透過提供宅配、現金回饋、折扣和廣泛支付選項的線上藥局網站和應用程式來獲得認知功能補充劑是多麼容易,該市場也在不斷成長。非專利補充劑可透過處方箋和非處方藥 (OTC) 輕鬆取得,通常用於緩解與認知障礙相關的疼痛。此外,越來越多的運動員在各種競技運動中使用認知功能補充劑也促進了積極的市場趨勢。

為什麼要購買這份報告?

  • 富有洞察力的分析:獲得涵蓋關鍵和新興地區的深入市場洞察,重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業和其他子區隔。
  • 競爭格局:了解世界主要企業採取的策略策略,並了解透過正確的策略滲透市場的潛力。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力做出策略決策,在動態環境中發現新的業務流和收益。
  • 受眾廣泛:對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用?

產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2022年至2029年歷史資料與預測
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長機會和預測細分市場和區域分析(包括國家)
  • 公司概況(尤其是重大發展)

全球認知功能補充品市場細分分析如下:

依產品類型

  • 天然分子
  • 草藥萃取物
  • 維生素和礦物質

按形式

  • 可咀嚼的
  • 膠囊

按分銷管道

  • 超級市場/大賣場
  • 醫藥店
  • 網路零售店
  • 其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他
  • 中東/非洲
  • 沙烏地阿拉伯
  • UAE
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球認知補充品市場:依產品類型

  • 介紹
  • 天然分子
  • 草藥萃取物
  • 維生素和礦物質

第6章全球認知補充品市場:依形式

  • 介紹
  • 可咀嚼的
  • 膠囊

第7章全球認知補充品市場:按分銷管道

  • 介紹
  • 超級市場/大賣場
  • 醫藥店
  • 網路零售店
  • 其他

第8章全球認知補充品市場:按地區

  • 介紹
  • 北美洲
    • 依產品類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 南美洲
    • 依產品類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 歐洲
    • 依產品類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 中東/非洲
    • 依產品類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 亞太地區
    • 依產品類型
    • 按形式
    • 按分銷管道
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Accelerated Intelligence
  • HVMN Inc.
  • Onnit Labs, Inc.(Unilever United States)
  • Liquid Health, Inc.
  • Quincy Bioscience-The Makers of Prevagen
  • Natural Factors Inc.
  • Jarrow Formulas, Inc.
簡介目錄
Product Code: KSI061615241

The Global cognition supplements market is predicted to expand at a CAGR of 13.79% to account for US$27.43 billion by 2030 from US$14.81 billion in 2025.

These Nootropics, or cognitive supplements, claim to improve memory, attention, and brain function in general. Caffeine, Ginkgo biloba, Bacopa monnieri, and omega-3 fatty acids are common components.

The need for cognitive health solutions among ageing populations hoping to preserve mental sharpness is driving the cognition supplements market. The market's growth is further aided by rising stress levels, hectic lifestyles, and the incidence of cognitive illnesses like Alzheimer's disease. Research demonstrating the effectiveness of certain substances and technological developments also contribute to market expansion. Furthermore, as individuals place a higher priority on general brain health and cognitive ability, the trend towards preventative healthcare and self-care rising demand for cognition supplements.

As per the World Health Organization, the population worldwide is rapidly ageing. One billion people worldwide were sixty years of age or older in 2020. By 2030, that number will have increased to 1.4 billion, or one in six persons on the planet. Furthermore, the population of those 60 and over will have doubled to 2.1 billion by 2050. It is anticipated that between 2020 and 2050, the number of people 80 years of age or older will triple, reaching 426 million.

Furthermore, to meet changing consumer preferences, market players in the cognition supplements industry use a variety of strategies, including investing in research for innovative formulations, forming strategic partnerships for wider distribution, and utilising branding and marketing techniques to differentiate their products and win over customers.

Additionally, based on clinical and scientific evidence, Probi(R) Sensia is a novel probiotic idea that enhances mood and sleep quality, improves working memory and learning, and promotes enhanced cognition. These brain processes are crucial for improving people's general mental well-being. The new probiotic solution is tailored with local assistance, available to suit a range of consumer demands, and backed by claims relevant to global health.

Comprehensively, the cognitive supplements market is expanding significantly due to reasons such as an ageing population, growing awareness of cognitive health, and a rise in demand for performance-enhancing products. Market participants are using a variety of tactics, including branding campaigns, strategic alliances, and research and development, to remain competitive in this ever-changing environment. Furthermore, the cognitive supplements market is expected to grow in the future due to shifting consumer preferences and the ability to create more potent formulations made possible by technological advancements.

Global cognition supplements market drivers

  • Growth in mental health diseases.

The cognitive supplements market is predicted to be significantly driven by the projected increase in mental health disorders. Complementary and alternative methods to enhance mental well-being are in greater demand due to the rising global prevalence of illnesses including anxiety, depression, and ADHD. Supplements claiming to elevate mood, lessen stress, and increase cognitive function are called cognition supplements, and they are positioned to meet this need. The cognitive supplements market is expected to increase significantly in the upcoming years as people look for ways to prevent and treat mental health concerns. This presents potential for innovation and growth in the industry.

An estimated 57.8 million people in the US who were 18 years of age or older had AMI in 2021. This figure accounted for 22.8% of all adult Americans. Women had a greater frequency of AMI (27.2%) than did men (18.1%). The frequency of AMI was highest in young people (18-25 years old) (33.7%), followed by adults (26-49 years old; 28.1%) and older individuals (15.0%).

Adults reporting two or more racial identities had the highest frequency of AMI (34.9%), followed by those who identified as American Indian or Alaskan Native (AI/AN) (26.6%). Asian adults had the lowest frequency of AMI (16.4%).

Additionally, the National Mental Health Programme (NMHP) is being implemented in India by the government to provide accessible and reasonably priced mental healthcare facilities. The National Health Mission offers support to States and UTs for the District Mental Health Programme (DMHP), a component of the NMHP, which has been approved for implementation in 704 districts. The DMHP provides outpatient services, assessment, counselling, psycho-social interventions, ongoing care and support for individuals with severe mental disorders, medication, outreach services, ambulance services, and other services at the Community Health Centre (CHC) and Primary Health Centre (PHC) levels.

Furthermore, self-reported mental and behavioural disorders are among the many health problems covered by the Australian Bureau of Statistics (ABS) 2020-21 National Health Survey. Only when an individual states that a mental or behavioural condition has lasted, or was anticipated to last, six months or more does the NHS record the individual as having a mental or behavioural condition during the collection period. A mental or behavioural disorder was estimated to have affected 1 in 5 (20%) Australians aged 15 and older during the collecting period (August 2020 to June 2021), according to the 2020-21 NHS (ABS 2022b).

Global cognition supplements market Geographical outlooks

  • The United States in the North American region is expected to hold significant shares of the Global cognition supplements market.

The ageing population is one of the primary causes of dementia and cognitive impairment. The number of elderly people in the United States has been steadily increasing, which has led to an increase in the prevalence of mental health conditions like dementia. Throughout the forecast period, this is expected to expand the product's application scope and boost overall market growth. For instance, the prevalence of Alzheimer's dementia rises with age: 5.0% of those 65 to 74, 13.1% of those 75 to 84, and 33.3% of those 85 years of age and above have the disease in the United States.

Further, consumer preferences have shifted in favour of herbal health products that contain ingredients like matcha tea, caffeine, beets, spinach, Brahmi, Arctic root, turmeric, ginseng, and pine bark in the last few years. Furthermore, it is anticipated that the growing vegan population in the United States will increase demand for herbal products.

Moreover, the dietary and natural supplement industries in this region are well-established, which will contribute to their high growth during the forecast period. For instance, it was projected that the total sales of dietary supplements in the United States in 2020 would be $55.7 billion, $21.2 billion were attributed to supplements that contain vitamins, minerals, or both, with $8.0 billion going toward multivitamins/minerals (MVM) and multivitamins (MVs).

Furthermore, the growing prevalence of mental health issues like anxiety, stress, and depression is supporting the industry's growth. For instance, the Anxiety and Depression Association of America estimates that 6.8 million adult Americans have general anxiety disorder, or GAD.

Further, social media platforms are becoming increasingly influential in consumer decision-making. In addition, the market is expanding as more people become aware of how simple it is to get cognitive supplements through online pharmacy websites and applications that offer home delivery, cashback, discounts, and a plethora of payment options. Typically, they involve generic supplements that are easily obtained by prescription or over-the-counter (OTC) to relieve pain related to cognitive disorders. Positive market trends are also being produced by athletes' increasing use of cognitive supplements for a variety of competitive sports.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Global cognition supplements market is segmented and analyzed as below:

By Product Type

  • Natural Molecules
  • Herbal Extract
  • Vitamins & Minerals

By Form

  • Chewable
  • Capsules

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Medical Stores
  • Online Retail Stores
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL COGNITION SUPPLEMENTS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Natural Molecules
  • 5.3. Herbal Extract
  • 5.4. Vitamins & Minerals

6. GLOBAL COGNITION SUPPLEMENTS MARKET BY FORM

  • 6.1. Introduction
  • 6.2. Chewable
  • 6.3. Capsules

7. GLOBAL COGNITION SUPPLEMENTS MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Supermarkets/Hypermarkets
  • 7.3. Medical Stores
  • 7.4. Online Retail Stores
  • 7.5. Others

8. GLOBAL COGNITION SUPPLEMENTS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Form
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Form
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Form
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Form
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Form
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Australia
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Accelerated Intelligence
  • 10.2. HVMN Inc.
  • 10.3. Onnit Labs, Inc. (Unilever United States)
  • 10.4. Liquid Health, Inc.
  • 10.5. Quincy Bioscience - The Makers of Prevagen
  • 10.6. Natural Factors Inc.
  • 10.7. Jarrow Formulas, Inc.